Status:
UNKNOWN
Indwelling Device-associated Biofilms
Lead Sponsor:
Grigore T. Popa University of Medicine and Pharmacy
Conditions:
Oncology
Critical Illness
Eligibility:
All Genders
18+ years
Brief Summary
Healthcare associated infections linked to the use of indwelling medical devices increase hospital morbidity, mortality and the Intensive Care treatment costs. The essential strategy for mitigating th...
Detailed Description
According to Regional Institute of Oncology, Iasi protocols, all septic patients with the need of invasive ventilatory support (endotracheal intubation), have concomitantly inserted a CVC, an AC and a...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Signed informed consent;
- Age ≥18 years;
- Suspected/proven sepsis/septic shock (Supplemental file 2);
- APACHE II score ≥10 (Supplemental file 3);
- Predictable invasive ventilatory support ≥ 48 hours;
- Patient estimated survival ≥ 4 days.
- Exclusion criteria:
- Patient/legal representative refusal;
- Age \<18 years;
- Chronic psychiatric/neurological disease with impaired decision-making capacity;
- Pregnancy;
- Invasive ventilatory support \< 2 days;
- Death in less than 4 days after ICU admission.
Exclusion
Key Trial Info
Start Date :
June 5 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 5 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04328818
Start Date
June 5 2019
End Date
October 5 2025
Last Update
March 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Regional Institute of Oncology
Iași, Romania, 7--483